SWOG clinical trial number
SWOG-9443 (NABTC-9402) (NCI T94-0087)
A Phase II Trial of Phenylacetic Acid for Recurrent Malignant Glioma and Primitive Neuroectodermal Tumors: A Clinical and Pharmacokinetics Study of the North American Brain Tumor Consortium
Closed
Phase
Accrual
100%
Abbreviated Title
A Phase II Trial of Phenylacetic Acid for Recurrent Malignant Glioma and Primitive Neuroectodermal Tumors: A Clinical and Pharmacokinetics Study of the North American Brain Tumor Consortium
Activated
12/27/1994
Closed
12/15/1997
Research committees
Brain Cancer